Y6N-76146-16197
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 920 / CA
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-22
Dose 2 — Pfizer-BioNTech
-
2021-03-23
Registered in v-safe
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-24
- 2021-03-25
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-19
- 2021-04-28
- 2021-05-03
- 2021-06-23
- 2021-09-20
-
2022-03-22
Survey response — 12 months, dose 2MedDRA: COVID-19, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pregnancy and Covid 19MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech |
Free text
Release 11 — 12 months, dose 2
Symptoms: Pregnancy and Covid 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release